Daxor Stock (NASDAQ:DXR)


Chart

Previous Close

$13.37

52W Range

$6.55 - $14.00

50D Avg

$12.29

200D Avg

$9.43

Market Cap

$66.44M

Avg Vol (3M)

$29.11K

Beta

-0.06

Div Yield

-

DXR Company Profile


Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

37

IPO Date

Jul 25, 1983

Website

DXR Performance


Latest Earnings Call Transcripts


Q2 22Aug 26, 22 | 7:06 PM

Peer Comparison


TickerCompany
ZJYLJin Medical International Ltd.
MDAISpectral AI, Inc.
NEUENeueHealth, Inc.
OTLKOutlook Therapeutics, Inc.
RLMDRelmada Therapeutics, Inc.
NEPHNephros, Inc.
TickerGate Footer Logo

Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks